• Publikační typ
• tisková chyba MeSH

x

x

Tularemie je zoonóza, jejíž původcem je Francisella tularensis, gramnegativní aerobní bakterie patřící do třídy Gammaproteobacteria a čeledi Francisellaceae. Navzdory skutečnosti, že F. tularensis může mít významný dopad na zdraví člověka, existuje o aktuálním výskytu tohoto patogenu v různých hematofágních členovcích pouze velmi málo údajů. Cílem studie bylo provést rozsáhlý molekulární screening různých potenciálních hematofágních vektorů: klíšťat (4348 jedinců druhů Ixodes ricinus, Dermacentor reticulatus a Haemaphysalis concinna), komárů (4100 jedinců druhu Aedes vexans) a muchniček (6900 jedinců Simulium spp.) na přítomnost F. tularensis na Břeclavsku v roce 2022. Pozitivní byly pouze 2 vzorky, které obsahovaly DNA specifickou pro F. tularensis subsp. holarctica. Oba vzorky pocházely z klíštěte D. reticulatus a to jak po infestaci srnce, tak jednoho směsného vzorku nasbíraných klíšťat (n = 10). Oba pozitivní vzorky byly sekvenovány a byla potvrzena přítomnost F. tularensis subsp. holarctica. Přítomnost

Tularemia is a zoonosis caused by Francisella tularensis, a gram-negative aerobic bacterium belonging to the class of Gammaproteobacteria and the family Francisellaceae. Despite its undeniable importance for human health, there is little data on the current distribution of F. tularensis in various hematophagous arthropods. The aim of this study was to perform a mass molecular screening of different possible hematophagous vectors: ticks (4348 ticks of the species Ixodes ricinus, Dermacentor reticulatus, and Haemaphysalis concinna), mosquitoes (4100 specimens of Aedes vexans), and blackflies (6900 specimens of the Simulium spp.) for the presence of F. tularensis in the Břeclav district in 2022. Only two specimens were positive for the specific DNA of Francisella tularensis subsp. holarctica. Both samples originated from D. reticulatus, one collected from infested roe deer and the other included in a pooled sample (n = 10). Both positive samples were sequenced, and the presence of F. tularensis subsp. holarctica was confirmed. In addition, the absence of F. tularensis in mosquitoes and black flies was documented.

• MeSH
• Francisella tularensis * patogenita   MeSH
• genetické techniky MeSH
• infekce přenášené vektorem * MeSH
• komáří přenašeči mikrobiologie   MeSH
• kontrola infekčních nemocí * metody   MeSH
• lidé MeSH
• nemoci přenášené klíšťaty epidemiologie   mikrobiologie   přenos   MeSH
• Simuliidae mikrobiologie   MeSH
• tularemie epidemiologie   mikrobiologie   přenos   MeSH
• zdroje nemoci mikrobiologie   MeSH
• Check Tag
• lidé MeSH
• Geografické názvy
• Česká republika MeSH

BACKGROUND: The Slovak Republic, an Eastern European country, borders Ukraine, which has one of the highest rates of HIV/AIDS in Europe. This study aims to inform readers about the demographic characteristics of Ukrainian war refugees with HIV/AIDS seeking temporary protection status in Slovakia due to the Russian invasion of February 24, 2022. It focuses on their epidemiology, immunological profiles, co-infections, and treatment. DESIGN: Multicenter, retrospective study between March 1, 2022, and March 31, 2023. METHODS: Data were collected from all Ukrainian patients with refugee status living with HIV or newly diagnosed, who presented to any of the five HIV/AIDS centers in Slovakia. Information was obtained through medical interviews, physical examinations, laboratory tests and medical reports from the Ukrainian Ministry of Health. RESULTS: From March 1, 2022, to March 31, 2023, 141 Ukrainian refugees were included, mostly women (56.7 %, n = 80), with a median age of 41 years. The median CD4+ count was 680 cells/mL; 69.2 % (n = 97) had a viral load below 40 copies/mL. On arrival, 87.8 % (n = 123) were on ART, 90.2 % (n = 111) on dolutegravir. Coinfections included hepatitis C (31 %, n = 41), hepatitis B (12.5 %, n = 17), and tuberculosis (11.3 %, n = 16). Three died from AIDS complications. CONCLUSION: The study provides a detailed overview of the epidemiological, demographic, immunological, co-infection, and treatment characteristics of Ukrainian PLWHA displaced by the war to the Slovak republic. With the conflict ongoing, it is necessary to be prepared for more refugees in the coming months.

• MeSH
• dospělí MeSH
• HIV infekce * epidemiologie   farmakoterapie   MeSH
• koinfekce epidemiologie   MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• počet CD4 lymfocytů MeSH
• retrospektivní studie MeSH
• uprchlíci * statistika a číselné údaje   MeSH
• virová nálož MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• multicentrická studie MeSH
• Geografické názvy
• Slovenská republika MeSH
• Ukrajina MeSH

INTRODUCTION: Mumps data were analysed to assess the effect of vaccination on mumps complications and hospitalisation. METHODS: The mumps cases reported to the Czech nationwide surveillance system from 2013 to 2022 were analysed using logistic regression with an odds ratio (aOR) adjusted for age, sex, year of onset and administrative region to measure the association between vaccination and complications or hospitalisation. Adjusted vaccine effectiveness (aVE) was calculated: aVE=(1-aOR)x100. RESULTS: A total of 11,913 mumps cases were reported, of which 6,885 (58%) were male. The median age of the study participants was 16 (range: 0-89 years). No complications occurred in 91% of patients. Mumps orchitis occurred in 633 (9%) male cases. A total of 946 (8%) patients required hospitalisation. The highest proportion of complications and hospitalisations was in the age group 35-44 years. Two doses of vaccine reduced statistically significantly the risk of any complications and of hospitalisation compared with unvaccinated patients: aOR 0.48 (95% CI: 0.37, 0.62), aVE of 52% (95% CI: 38, 63); and aOR 0.43 (95% CI: 0.33, 0.56), aVE of 57% (95% CI: 44, 67), respectively. Two doses showed statistically significant aVE 50% (95% CI: 32, 64) against orchitis, and 59% (95% CI: 23, 79) against meningitis. Among the two-dose recipients, the proportion of complications increased gradually with the time from the second dose. CONCLUSIONS: Our findings demonstrated a protective effect of two-dose vaccination against mumps complications and hospitalisation for mumps. We recommend continuing routine childhood mumps vaccination and maintaining high MMR coverage in Czechia.

• Publikační typ
• časopisecké články MeSH

BACKGROUND: By March, 2023, 54 countries, areas, and territories (hereafter CAT) in the WHO European Region had reported more than 2·2 million COVID-19-related deaths to the WHO Regional Office for Europe. Here, we estimated how many lives were directly saved by vaccinating adults in the WHO European Region from December, 2020, to March, 2023. METHODS: In this retrospective surveillance study, we estimated the number of lives directly saved by age group, vaccine dose, and circulating variant-of-concern (VOC) period, regionally and nationally, using weekly data on COVID-19 mortality and infection, COVID-19 vaccination uptake, and SARS-CoV-2 virus characterisations by lineage downloaded from The European Surveillance System on June 11, 2023, as well as vaccine effectiveness data from the literature. We included data for six age groups (25-49 years, 50-59 years, ≥60 years, 60-69 years, 70-79 years, and ≥80 years). To be included in the analysis, CAT needed to have reported both COVID-19 vaccination and mortality data for at least one of the four older age groups. Only CAT that reported weekly data for both COVID-19 vaccination and mortality by age group for 90% of study weeks or more in the full study period were included. We calculated the percentage reduction in the number of expected and reported deaths. FINDINGS: Between December, 2020, and March, 2023, in 34 of 54 CAT included in the analysis, COVID-19 vaccines reduced deaths by 59% overall (CAT range 17-82%), representing approximately 1·6 million lives saved (range 1·5-1·7 million) in those aged 25 years or older: 96% of lives saved were aged 60 years or older and 52% were aged 80 years or older; first boosters saved 51% of lives, and 60% were saved during the Omicron period. INTERPRETATION: Over nearly 2·5 years, most lives saved by COVID-19 vaccination were in older adults by first booster dose and during the Omicron period, reinforcing the importance of up-to-date vaccination among the most at-risk individuals. Further modelling work should evaluate indirect effects of vaccination and public health and social measures. FUNDING: US Centers for Disease Control and Prevention.

• MeSH
• COVID-19 * prevence a kontrola   mortalita   epidemiologie   MeSH
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• očkovací programy statistika a číselné údaje   MeSH
• retrospektivní studie MeSH
• SARS-CoV-2 * imunologie   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• Světová zdravotnická organizace MeSH
• vakcíny proti COVID-19 * aplikace a dávkování   MeSH
• Check Tag
• dospělí MeSH
• lidé středního věku MeSH
• lidé MeSH
• mužské pohlaví MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Evropa MeSH

Práce hodnotí vývoj úmrtnosti na chronickou obstrukční plicní nemoc (CHOPN) v České republice v období let 2001-2021 na podkladě údajů Českého statistického úřadu s využitím absolutních počtů zemřelých a standardizované míry úmrtnosti a dává úmrtnost na CHOPN do kontextu úmrtí na ostatní respirační příčiny. Během sledovaných 21 let třetího tisíciletí zemřelo na CHOPN 53 923 osob. Počty zemřelých mužů a žen narůstaly z 1 069 a 605 v roce 2001 na maximum 2 143 a 1 451 v roce 2015 a poté poklesly na 1 800 a 1 231 v roce 2021. Mezi roky 2001 a 2021 došlo ke zvýšení počtu zemřelých na CHOPN o 68 % u mužů a o 103 % u žen. Standardizovaná úmrtnost na 100 000 obyvatel, která poskytuje realističtější obrázek vývoje díky vyloučení vlivu věkové struktury porovnávaných let, vzrostla mezi roky 2001 a 2021 u mužů o 6,1 % a u žen o 34,7 %. Poměr úmrtí mezi muži a ženami klesl z 2,73 na 2,15. Úmrtnost na CHOPN je v České republice nadále poměrně vysoká, je mírně vyšší než průměr v Evropské unii. Ve sledovaném období stoupla, podobně jako v jiných zemích, hlavně u žen.

x

• MeSH
• chronická obstrukční plicní nemoc * mortalita   MeSH
• lidé MeSH
• sběr dat statistika a číselné údaje   MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• přehledy MeSH
• Geografické názvy
• Česká republika MeSH

Background: Tick-borne encephalitis (TBE) is caused by the tick-borne encephalitis virus (TBEV). TBEV infection can cause symptoms of central nervous system (CNS) inflammation and result in severe consequences including death. TBE is an increasing health threat in the Czech Republic and elsewhere in Europe. In 2020, 23% of 3734 TBE cases reported to the European Centre for Disease Prevention and Control were from the Czech Republic. TBE vaccination is universally recommended in the Czech Republic, but a full analysis of TBE vaccine effectiveness (VE) in the Czech Republic has not been published. Methods: TBE is a notifiable disease in the Czech Republic with mandatory reporting of cases (i.e., laboratory-confirmed TBEV infected patient with symptoms of CNS inflammation) and vaccination history to public health authorities. TBE VE was estimated using the screening method utilizing public health surveillance data from 2018 to 2022 and online household surveys of the general population on TBE vaccine uptake conducted in 2019-2022. Results: In 2018-2022, 3648 TBE cases were reported in the Czech Republic; 98.1% (3105/3166) of TBE cases with known vaccination history were unvaccinated. Among 42,671 persons surveyed from the general population who had known TBE vaccination history, 66.5% were unvaccinated. VE against TBE was 97.6% (95% confidence interval 95.7-98.7). When stratified by age group, VE was 97.1% (88.4-99.3) in 1-15 years of age, 97.9% (95.3-99.0) in 16-59 years of age, and 96.9% (90.5-99.0) in ≥60 years of age. TBE vaccination averted an estimated 1020 TBE cases in the Czech Republic from 2018 to 2022. Conclusions: This first published study with a full analysis of TBE VE in the Czech Republic showed that vaccination was highly effective for the prevention of TBE including in children, an age group with increasing TBE disease burden. Vaccination averted hundreds of TBE cases and hospitalizations despite the relatively low compliance with TBE vaccine recommendations. To prevent additional TBE cases in the Czech Republic, enhanced efforts to increase TBE vaccine uptake are needed.

• MeSH
• dítě MeSH
• dospělí MeSH
• klíšťová encefalitida * prevence a kontrola   epidemiologie   MeSH
• kojenec MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• předškolní dítě MeSH
• senioři MeSH
• vakcinace * MeSH
• virové vakcíny * aplikace a dávkování   MeSH
• viry klíšťové encefalitidy * imunologie   MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• kojenec MeSH
• lidé středního věku MeSH
• lidé MeSH
• mladiství MeSH
• mladý dospělý MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• senioři MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika MeSH

• MeSH
• lidé MeSH
• pití alkoholu * epidemiologie   MeSH
• průzkumy a dotazníky MeSH
• užívání tabáku epidemiologie   MeSH
• Check Tag
• lidé MeSH